Pyrazoloacridine (PD 115934) is a dual topoisomerase I/II inhibitor with an IC50 of 1.25 µM in K562 cells. This nucleic acid-binding agent exhibits anticancer activity and has been investigated in both in vitro cytotoxicity assays and in vivo preclinical tumor models.
Molekulargewicht:
367.4
Reinheit:
99.72% (May vary between batches)
CAS Nummer:
[99009-20-8]
Formel:
C19H21N5O3
Target-Kategorie:
Topoisomerase,Apoptosis
Anwendungsbeschreibung:
Solubility: DMSO:5.22 mg/mL (14.21 mM)
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten